Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors
Anyone can follow the GOLO for Life Plan successfully
Month 1: 0.5 mg, once daily Month 2: 1 mg, once daily Month 3: 1.5 mg, once daily Month 4: 2 mg, once daily Month 5 and beyond (maintenance): 2.5 mg, once daily Medication is prescribed only after consultation with a licensed provider to determine appropriateness
The second most common is step therapy failure, meaning you have not tried enough lower-cost medications first
Download the guide now to get expert strategies and support your patients journey with GLP-1 treatments: #Resources #ClinicianGuide #GLP-1 Managing GLP-1 therapy side effects with a Clinician Guide Struggling with GLP-1 therapy side effects
Each session takes just 10 minutes